Insider Trading & Ownership - Sethuraman Natarajan

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Sethuraman Natarajan
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-05-16
Sale
2024-05-20
5:26 pm
Entrada Therapeutics Inc.TRDASethuraman Natarajan
Chief Scientific Officer
18,980$15.16$287,695190,052
(Direct)
View
2023-07-10
Sale
2023-07-12
4:32 pm
Entrada Therapeutics Inc.TRDASethuraman Natarajan
Chief Scientific Officer
17,878$18.03$322,389153,447
(Direct)
View
2023-04-17
Sale
2023-04-19
6:06 pm
Entrada Therapeutics Inc.TRDASethuraman Natarajan
Chief Scientific Officer
3,961$18$71,316171,325
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-03-05
Tax Withholding
2024-03-05
7:44 pm
N/A
N/A
Entrada Therapeutics Inc.TRDASethuraman Natarajan
Chief Scientific Officer
1,505$12.28275,832
(Direct)
View
2024-03-01
Option Award
2024-03-05
7:44 pm
N/A
2034-03-01
Entrada Therapeutics Inc.TRDASethuraman Natarajan
Chief Scientific Officer
110,900$0275,832
(Direct)
View
2024-03-04
Tax Withholding
2024-03-05
7:44 pm
N/A
N/A
Entrada Therapeutics Inc.TRDASethuraman Natarajan
Chief Scientific Officer
347$12.42275,832
(Direct)
View
2024-03-04
Tax Withholding
2024-03-05
7:44 pm
N/A
N/A
Entrada Therapeutics Inc.TRDASethuraman Natarajan
Chief Scientific Officer
414$13.37275,832
(Direct)
View
2023-09-01
Option Award
2023-09-06
5:09 pm
N/A
2033-09-01
Entrada Therapeutics Inc.TRDASethuraman Natarajan
Chief Scientific Officer
35,700$0188,698
(Direct)
View
2023-09-05
Tax Withholding
2023-09-06
5:09 pm
N/A
N/A
Entrada Therapeutics Inc.TRDASethuraman Natarajan
Chief Scientific Officer
449$14.46188,698
(Direct)
View
2023-03-01
Option Award(A)
2023-04-19
5:50 pm
N/A
2033-03-01
Entrada Therapeutics Inc.TRDASethuraman Natarajan
Chief Scientific Officer
35,700$0196,786
(Direct)
View
2023-03-01
Option Award
2023-03-03
4:36 pm
N/A
2033-03-01
Entrada Therapeutics Inc.TRDASethuraman Natarajan
Chief Scientific Officer
71,400$0232,486
(Direct)
View
2023-03-02
Tax Withholding
2023-03-03
4:36 pm
N/A
N/A
Entrada Therapeutics Inc.TRDASethuraman Natarajan
Chief Scientific Officer
1,058$11.6232,486
(Direct)
View
2022-09-01
Option Award
2022-09-06
4:33 pm
N/A
N/A
Entrada Therapeutics Inc.TRDASethuraman Natarajan
Chief Scientific Officer
5,794$0162,144
(Direct)
View
2022-07-01
Option Award
2022-07-06
4:16 pm
N/A
2032-07-01
Entrada Therapeutics Inc.TRDASethuraman Natarajan
Chief Scientific Officer
34,763$034,763
(Direct)
View
2022-03-01
Option Award
2022-03-03
4:10 pm
N/A
2032-03-01
Entrada Therapeutics Inc.TRDASethuraman Natarajan
Chief Scientific Officer
81,113$0225,875
(Direct)
View
2021-10-28
Option Award
2021-11-01
7:02 pm
N/A
2031-10-28
Entrada Therapeutics Inc.TRDASethuraman Natarajan
Chief Scientific Officer
243,639$0243,639
(Direct)
View

Ownership
2021-10-28
9:01 pm
N/A
N/A
Entrada Therapeutics Inc.TRDASethuraman Natarajan
Chief Scientific Officer
0$0323,881
(Direct)
View
(A) Indicate amendment filing.